Osteotech has continued to work closely with a French Regulatory Agency to resolve the perceived irregularities in the documentation associated with certain donated tissue from its Bulgarian subsidiary. While this review did not question the safety or performance of any of Osteotech's products, the company temporarily suspended the distribution of products processed from tissue recovered in Bulgaria. In late April, the French Regulatory Agency completed its follow-up audit of Osteotech's Bulgarian operations and did not have any audit findings in its final closing discussions. The company is currently waiting on a final decision from the French Regulatory Agency before lifting its temporary suspension.